Forward-thinking pharma companies are now implementing a ‘content excellence’ approach to unlock the potential of omnichannel. New procedures and practices are enabling greater content volume —and more personalized engagement — without exponential cost increases. But how are they doing it? And what are the essential elements of a content excellence approach in pharma?
During our last webinar with Impatient Health, and speakers from Astellas, Janssen, and Abbott, we discussed the challenges of marketing in a post-covid world — and how a content excellence approach enables omnichannel and more personalized HCP engagement through improved content efficiency.
In our webinar we explain how to achieve this in practical terms. Peers from Novo Nordisk will present real cases and success stories (along with some of their challenges!) of implementing content excellence in their organisations.
You will learn:
Global Director Marketing Operations, NovoNordisk
Chief Technology Officer, Anthill
Chief Executive Officer, Impatient Health
Advanced Engagement Analytics Lead Commercial Excellence & Operations
Global Lead - Modular Content, Multichannel Excellence & Operations Commercial Excellence
Associate Manager, Global Commercial Solutions (GCS)